Evaluation of Commutability of Processed Samples; Approved Guideline, Third Edition, EP14A3Estandard by Clinical and Laboratory Standards Institute, 08/15/2014

Nucleic Acid Amplification Assays for Molecular Hematopathology; Approved Guideline-Second Edition,MM05A2Estandard by Clinical and Laboratory Standards Institute, 03/01/2012

Urine Drug Testing in the Clinical Laboratory; Approved Guideline, T/DM08-Astandard by Clinical and Laboratory Standards Institute, 02/01/1999

Establishing Molecular Testing in Clinical Laboratory Environments; Proposed Guideline, MM19AEstandard by Clinical and Laboratory Standards Institute, 11/01/2011

Methods for Antimicrobial Susceptibility Testing for Human Mycoplasmas; Approved Guideline, M43AEstandard by Clinical and Laboratory Standards Institute, 10/01/2011

Qualifying, Selecting, and Evaluating a Referral Laboratory, 3rd Edition, QMS05Ed3Estandard by Clinical and Laboratory Standards Institute, 06/02/2020

Methods for Antimicrobial Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria Isolated From Animals, 1st Edition, VET06Ed1Estandard by Clinical and Laboratory Standards

Newborn Blood Spot Screening for Pompe Disease by Lysosomal Acid alpha-Glucosidase Activity Assays, 1st Edition, NBS07Ed1Estandard by Clinical and Laboratory Standards Institute,

User Protocol for Evaluation of Qualitative Test Performance; Approved Guideline, Second Edition, EP122Astandard by Clinical and Laboratory Standards Institute, 01/01/2008

Management of Nonconforming Laboratory Events, QMS11Ed2Estandard by Clinical and Laboratory Standards Institute, 08/25/2015

Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria; Third Edition, M45Ed3EA2Estandard by Clinical and Laboratory Standards

Proceedings From the QC for the Future Workshop; A Report, X06-RConference Proceeding by Clinical and Laboratory Standards Institute, 06/01/2005